CVS Health Corp
CVS79.080USD
+1.040+1.33%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
100.43BMarket Cap
210.43P/E TTM
More Details of CVS Health Corp Company
CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, PDPs and Medicaid health care management services. The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells an assortment of health and wellness products and general merchandise.
CVS Health Corp Info
Ticker SymbolCVS
Company nameCVS Health Corp
IPO dateNov 06, 2088
CEOJoyner (J. David David)
Number of employees300000
Security typeOrdinary Share
Fiscal year-endNov 06
AddressOne Cvs Dr.
CityWOONSOCKET
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code02895
Phone14017651500
Websitehttps://cvshealth.com/
Ticker SymbolCVS
IPO dateNov 06, 2088
CEOJoyner (J. David David)
Company Executives of CVS Health Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Larry Robbins
Mr. Larry Robbins
Independent Director
Independent Director
11.95M
--
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Lead Independent Director
Lead Independent Director
45.91K
+0.31%
Mr. Tilak Mandadi
Mr. Tilak Mandadi
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
40.60K
-13.94%
Mr. Steven H. Nelson
Mr. Steven H. Nelson
Executive Vice President and President - Aetna
Executive Vice President and President - Aetna
21.33K
--
Mr. Guy P. Sansone
Mr. Guy P. Sansone
Independent Director
Independent Director
13.66K
+13.76%
Mr. Douglas H. (Doug) Shulman, J.D.
Mr. Douglas H. (Doug) Shulman, J.D.
Independent Director
Independent Director
5.93K
+38.63%
Ms. Leslie V. Norwalk
Ms. Leslie V. Norwalk
Director
Director
5.93K
+38.63%
Mr. Roger N. Farah
Mr. Roger N. Farah
Director
Director
4.12K
-92.40%
Ms. Alecia A. Decoudreaux, J.D.
Ms. Alecia A. Decoudreaux, J.D.
Independent Director
Independent Director
2.97K
--
Dr. Amy L. Compton-Phillips, M.D.
Dr. Amy L. Compton-Phillips, M.D.
Executive Vice President and Chief Medical Officer
Executive Vice President and Chief Medical Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Larry Robbins
Mr. Larry Robbins
Independent Director
Independent Director
11.95M
--
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Lead Independent Director
Lead Independent Director
45.91K
+0.31%
Mr. Tilak Mandadi
Mr. Tilak Mandadi
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
40.60K
-13.94%
Mr. Steven H. Nelson
Mr. Steven H. Nelson
Executive Vice President and President - Aetna
Executive Vice President and President - Aetna
21.33K
--
Mr. Guy P. Sansone
Mr. Guy P. Sansone
Independent Director
Independent Director
13.66K
+13.76%
Mr. Douglas H. (Doug) Shulman, J.D.
Mr. Douglas H. (Doug) Shulman, J.D.
Independent Director
Independent Director
5.93K
+38.63%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
By BusinessUSD
Name
Revenue
Proportion
Pharmacy
55.35B
55.96%
Premiums
34.20B
34.57%
Front Store
5.37B
5.43%
Other
3.52B
3.55%
Net investment income(loss)
487.00M
0.49%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Pharmacy
55.35B
55.96%
Premiums
34.20B
34.57%
Front Store
5.37B
5.43%
Other
3.52B
3.55%
Net investment income(loss)
487.00M
0.49%
Shareholding Stats
Updated: Sat, Nov 15
Updated: Sat, Nov 15
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.31%
Dodge & Cox
5.76%
Capital World Investors
5.39%
BlackRock Institutional Trust Company, N.A.
5.07%
State Street Investment Management (US)
4.64%
Other
69.82%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.31%
Dodge & Cox
5.76%
Capital World Investors
5.39%
BlackRock Institutional Trust Company, N.A.
5.07%
State Street Investment Management (US)
4.64%
Other
69.82%
Shareholder Types
Shareholders
Proportion
Investment Advisor
46.52%
Investment Advisor/Hedge Fund
31.44%
Hedge Fund
3.09%
Research Firm
2.77%
Pension Fund
2.16%
Bank and Trust
1.96%
Sovereign Wealth Fund
1.65%
Individual Investor
1.06%
Insurance Company
0.10%
Other
9.25%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
3559
1.14B
91.37%
+184.05K
2025Q3
3681
1.14B
91.69%
+21.03M
2025Q2
3720
1.12B
91.24%
+11.94M
2025Q1
3762
1.11B
87.65%
+493.45K
2024Q4
3844
1.07B
85.40%
+28.70M
2024Q3
3797
1.04B
85.89%
-7.86M
2024Q2
3821
1.05B
84.06%
+19.75M
2024Q1
3841
1.03B
84.50%
-33.86M
2023Q4
3855
1.05B
81.50%
+16.24M
2023Q3
3736
1.03B
81.41%
+4.51M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
119.78M
9.44%
+2.04M
+1.74%
Jun 30, 2025
Dodge & Cox
73.29M
5.78%
-170.36K
-0.23%
Jun 30, 2025
Capital World Investors
66.96M
5.28%
-1.44M
-2.10%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
63.56M
5.01%
-1.40M
-2.15%
Jun 30, 2025
State Street Investment Management (US)
58.79M
4.64%
+800.41K
+1.38%
Jun 30, 2025
Fidelity Management & Research Company LLC
37.59M
2.96%
+13.37M
+55.22%
Jun 30, 2025
Geode Capital Management, L.L.C.
28.64M
2.26%
+675.82K
+2.42%
Jun 30, 2025
Capital International Investors
26.39M
2.08%
+202.05K
+0.77%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
19.70M
1.55%
+994.06K
+5.31%
Jun 30, 2025
BlackRock Investment Management, LLC
16.04M
1.26%
+10.29M
+178.77%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares U.S. Healthcare Providers ETF
12.05%
Invesco S&P Ultra Dividend Revenue ETF
6.26%
Coastal Compass 100 ETF
5.67%
Davis Select US Equity ETF
5.6%
Simplify Health Care ETF
5.48%
VanEck Retail ETF
4.53%
iShares US Consumer Staples ETF
4.18%
Invesco S&P 500 Pure Value ETF
3.71%
Invesco S&P 500 Enhanced Value ETF
3.03%
JPMorgan Healthcare Leaders ETF
2.99%
View more
iShares U.S. Healthcare Providers ETF
Proportion12.05%
Invesco S&P Ultra Dividend Revenue ETF
Proportion6.26%
Coastal Compass 100 ETF
Proportion5.67%
Davis Select US Equity ETF
Proportion5.6%
Simplify Health Care ETF
Proportion5.48%
VanEck Retail ETF
Proportion4.53%
iShares US Consumer Staples ETF
Proportion4.18%
Invesco S&P 500 Pure Value ETF
Proportion3.71%
Invesco S&P 500 Enhanced Value ETF
Proportion3.03%
JPMorgan Healthcare Leaders ETF
Proportion2.99%
Dividend
A total of
14.66B
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Sep 17, 2025
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Nov 03, 2025 going ex on Oct 23, 2025
Oct 23, 2025
Nov 03, 2025
Oct 23, 2025
Jul 07, 2025
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Aug 01, 2025 going ex on Jul 22, 2025
Jul 22, 2025
Aug 01, 2025
Jul 22, 2025
Mar 20, 2025
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on May 01, 2025 going ex on Apr 22, 2025
Apr 22, 2025
May 01, 2025
Apr 22, 2025
Jan 03, 2025
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Feb 03, 2025 going ex on Jan 23, 2025
Jan 23, 2025
Feb 03, 2025
Jan 23, 2025
Sep 19, 2024
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Nov 01, 2024 going ex on Oct 21, 2024
Oct 21, 2024
Nov 01, 2024
Oct 21, 2024
Jul 08, 2024
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Aug 01, 2024 going ex on Jul 22, 2024
Jul 22, 2024
Aug 01, 2024
Jul 22, 2024
Mar 21, 2024
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on May 01, 2024 going ex on Apr 19, 2024
Apr 22, 2024
May 01, 2024
Apr 19, 2024
Dec 06, 2023
CVS.NB Final Cash Dividend of gross USD 0.665 paid on Feb 01, 2024 going ex on Jan 19, 2024
Jan 22, 2024
Feb 01, 2024
Jan 19, 2024
Sep 21, 2023
CVS.NB Interim Cash Dividend of gross USD 0.605 paid on Nov 01, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 01, 2023
Oct 19, 2023
Jul 07, 2023
CVS.NB Interim Cash Dividend of gross USD 0.605 paid on Aug 01, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Aug 01, 2023
Jul 20, 2023
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of CVS Health Corp?
The top five shareholders of CVS Health Corp are:
The Vanguard Group, Inc. holds 119.78M shares, accounting for 9.44% of the total shares.
Dodge & Cox holds 73.29M shares, accounting for 5.78% of the total shares.
Capital World Investors holds 66.96M shares, accounting for 5.28% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 63.56M shares, accounting for 5.01% of the total shares.
State Street Investment Management (US) holds 58.79M shares, accounting for 4.64% of the total shares.
The Vanguard Group, Inc. holds 119.78M shares, accounting for 9.44% of the total shares.
Dodge & Cox holds 73.29M shares, accounting for 5.78% of the total shares.
Capital World Investors holds 66.96M shares, accounting for 5.28% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 63.56M shares, accounting for 5.01% of the total shares.
State Street Investment Management (US) holds 58.79M shares, accounting for 4.64% of the total shares.
What are the top three shareholder types of CVS Health Corp?
The top three shareholder types of CVS Health Corp are:
The Vanguard Group, Inc.
Dodge & Cox
Capital World Investors
The Vanguard Group, Inc.
Dodge & Cox
Capital World Investors
How many institutions hold shares of CVS Health Corp (CVS)?
As of 2025Q4, 3559 institutions hold shares of CVS Health Corp, with a combined market value of approximately 1.14B, accounting for 91.37% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.32%.
What is the biggest source of revenue for CVS Health Corp?
In FY2025Q2, the Pharmacy business generated the highest revenue for CVS Health Corp, amounting to 55.35B and accounting for 55.96% of total revenue.
